Early mortality in atezolizumab/bevacizumab for HCC is associated with impaired liver function and alterations of systemic immunity
阿特珠单抗/贝伐珠单抗治疗肝细胞癌的早期死亡与肝功能受损和全身免疫改变有关。
期刊:Jhep Reports
影响因子:7.5
doi:10.1016/j.jhepr.2025.101513
Piseddu, Ignazio; Jochheim, Leonie S; Boettcher, Katrin; Scheiner, Bernhard; Sinner, Friedrich; Gairing, Simon Johannes; Thaler, Matthias; Enssle, Stefan; Karin, Monika; Zarka, Valentina; Philipp, Alexander; Thalmeier, Andreas; Gaertig, Jan; Balcar, Lorenz; Schütte, Julia Martina; Schneider, Julia S; Ondrejkova, Katarina; Rau, Monika; Weich, Alexander; Anz, David; Berger, Karin; Schulz, Christian; Lange, Christian M; Öcal, Osman; Alunni-Fabbroni, Marianna; Ricke, Jens; Ehmer, Ursula; Venerito, Marino; Foerster, Friedrich; Pinter, Matthias; Geier, Andreas; Mayerle, Julia; De Toni, Enrico N; Reiter, Florian P; Ben Khaled, Najib
